Improving Medicines use in People with Polypharmacy in Primary Care (IMPPP)

niversity of Bristol0 个研究点目标入组 1,983 人开始时间: 2019年3月28日最近更新: 2023年11月6日

试验速览

2022 Protocol article in https://doi.org/10.3310/nihropenres.13285.1 (added 06/06/2023)

•Persons experiencing potentially problematic polypharmacy in primary care and community settings. This will specifically include hard to reach” groups, including nursing home residents, housebound individuals, and those who lack capacity to consent (e.g. dementia).
•The exact patient population will be defined as part of the case finding approach to be determined by the development phase (Phase 1) of the project. It is anticipated the case finding tool will identify older people (=60 years) who are receiving 10 or more medications regularly on prescription. This is because people in this group are more likely than younger people on fewer medications to trigger at least one of the prescribing quality indicators (being defined within Phase 1) which will underpin the case finding approach.

•1. Individuals receiving end-of-life care
•2. Patients judged by their GP to have chaotic medication use (e.g. history of drug or alcohol misuse)
•3. The GP deems contact to be inappropriate; for example, due to severe mental health problems, terminal illness, recent bereavement
•4. Participant is unable to complete the study questionnaires or medication review appointment (either themselves or with the help of carers)
•5. Individuals planning to move GP practice within the 6-month follow-up period

发起方

niversity of Bristol